drugset / Trial / NCT00468104

Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/Empyemas

NCT00468104

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to document the efficacy and safety of intrapleural instillation of Activase vs Placebo in the management of complicated pleural effusions and empyemas

Timeline

Start
2004-04
Primary completion
2008-10
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alteplase Protein / enzyme biologic 25 mg Other

Indications